Siren, L.L.C.
CIK 2005245 · View on SEC EDGAR ↗
- Portfolio value
- $4.9B
- Positions
- 117
- As of
- June 30, 2026
#825 of 9,443 by 13F value · top 8.7%
Portfolio value QoQ: +37.0% 13F does not disclose cash
- Top 10 holdings weight
- 45.32%
- Top 25 holdings weight
- 70.08%
- Positions above 1%
- 30
- Effective number of positions
- 30.8
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 11.42% Est. buys $824,100,152 · sells $480,524,308
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 47.8% still held
- New positions
- 27
- Increased
- 31
- Decreased
- 21
- Closed
- 10
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +51.5% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 98.3% · Options excluded: 0.0%
Sector breakdown
Healthcare
85.8%
Technology
3.5%
Communication Services
1.6%
Financial Services
1.4%
Retail
0.4%
Industrials
0.2%
Consumer Discretionary
0.0%
Real Estate
0.0%
Communications
0.0%
Telecommunication
0.0%
Financials
0.0%
Other/Unmapped
7.1%
Full portfolio 117 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corporation - Common Stock | $526,625,715 | 10.82% | 9,575,013 | $-5,531,924 | Down ×1 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $336,651,626 | 6.92% | 2,935,830 | $71,220,555 | Down ×3 | ||
| ERAS Erasca, Inc. - Common Stock | $208,807,348 | 4.29% | 11,397,781 | $26,875,448 | Up ×2 | ||
| MANE Veradermics, Incorporated Common Stock | $203,511,680 | 4.18% | 1,655,374 | $108,447,312 | Up ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $193,166,919 | 3.97% | 6,179,364 | $74,820,282 | Up ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $168,552,000 | 3.46% | 900,000 | $60,509,195 | Down ×2 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $166,352,179 | 3.42% | 5,602,970 | $50,931,106 | Down ×1 | ||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $139,828,449 | 2.87% | 1,715,476 | $38,538,104 | Up ×2 | ||
| ONC BeOne Medicines Ltd. - American Depositary Shares | $132,511,050 | 2.72% | 465,000 | $-5,580,000 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $129,391,476 | 2.66% | 3,184,629 | $-10,161,809 | Down ×2 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $126,160,613 | 2.59% | 1,136,275 | $63,062,921 | Up ×2 | ||
| LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | $106,328,443 | 2.19% | 44,303,518 | $37,214,955 | |||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $90,051,358 | 1.85% | 1,774,411 | $60,799,299 | Up ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $85,992,130 | 1.77% | 968,598 | $44,702,047 | Up ×1 | ||
| Unknown issuer (CUSIP: 698955101) | $81,898,129 | 1.68% | 2,992,259 | Up ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $79,588,523 | 1.64% | 1,318,564 | $2,914,026 | |||
| SLDB Solid Biosciences Inc. - Common Stock | $76,827,146 | 1.58% | 7,690,405 | $21,456,230 | |||
| ABVX Abivax SA - American Depositary Shares | $76,757,760 | 1.58% | 576,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 423494103) | $76,649,413 | 1.58% | 2,086,834 | Up ×1 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $71,954,097 | 1.48% | 1,859,279 | $6,163,948 | Up ×2 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $68,291,500 | 1.40% | 3,650,000 | Up ×1 | |||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $67,055,203 | 1.38% | 9,846,579 | $27,585,492 | Up ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $66,772,951 | 1.37% | 1,419,493 | $49,394,533 | Up ×1 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $65,287,754 | 1.34% | 1,995,347 | $319,256 | |||
| IRON Disc Medicine, Inc. - Common Stock | $64,977,649 | 1.34% | 888,401 | $1,779,289 | Down ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $64,655,121 | 1.33% | 758,952 | $24,189,545 | Up ×1 | ||
| SEPN Septerna, Inc. - Common Stock | $63,631,000 | 1.31% | 1,900,000 | $15,571,000 | Down ×1 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $60,760,432 | 1.25% | 4,856,949 | $-10,165,678 | Up ×2 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $53,165,887 | 1.09% | 1,420,788 | $-15,974,173 | Down ×1 | ||
| Unknown issuer (CUSIP: 482931102) | $48,780,721 | 1.00% | 2,214,286 | Up ×1 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $47,287,866 | 0.97% | 2,129,125 | $6,873,830 | Down ×4 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $46,852,139 | 0.96% | 872,967 | $-17,191,105 | Down ×1 | ||
| TBLA Taboola.com Ltd. - Ordinary Shares | $42,117,050 | 0.87% | 8,423,410 | $11,211,615 | Down ×1 | ||
| PVLA Palvella Therapeutics, Inc. - Common Stock | $39,348,858 | 0.81% | 257,485 | $7,253,353 | |||
| SLN Silence Therapeutics Plc - American Depository Share | $36,359,589 | 0.75% | 3,311,438 | $21,016,311 | Up ×1 | ||
| DNLI Denali Therapeutics Inc. - Common Stock | $35,918,314 | 0.74% | 1,396,513 | $9,105,264 | |||
| RELY Remitly Global, Inc. - Common stock | $34,584,703 | 0.71% | 1,543,271 | $10,401,646 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $34,478,996 | 0.71% | 1,893,410 | $17,520,640 | Up ×1 | ||
| COF Capital One Financial Corporation Common Stock | $34,429,401 | 0.71% | 171,615 | Up ×1 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $33,325,070 | 0.68% | 1,786,867 | $12,007,747 | |||
| GOOGL Alphabet Inc. - Class A Common Stock | $32,163,300 | 0.66% | 90,000 | $13,269,745 | Up ×2 | ||
| DBVT DBV Technologies S.A. - American Depositary Shares | $30,460,737 | 0.63% | 1,857,362 | $-8,339,555 | |||
| ABSI Absci Corporation - Common Stock | $28,682,515 | 0.59% | 2,474,764 | $23,282,515 | Up ×1 | ||
| SION Sionna Therapeutics, Inc. - Common Stock | $26,856,555 | 0.55% | 610,515 | $14,829,555 | Up ×1 | ||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $26,730,013 | 0.55% | 641,469 | $6,658,448 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $26,591,325 | 0.55% | 1,480,586 | $9,494,325 | Up ×1 | ||
| ANNX Annexon, Inc. - common stock | $25,458,869 | 0.52% | 4,458,646 | $3,527,970 | Up ×1 | ||
| MNPR Monopar Therapeutics Inc. - Common Stock | $25,010,226 | 0.51% | 270,118 | $10,210,461 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $23,792,500 | 0.49% | 250,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 81221K108) | $23,790,264 | 0.49% | 1,095,316 | Up ×1 | |||
| GLTO Galecto, Inc. - Common Stock | $23,409,000 | 0.48% | 900,000 | $99,000 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $23,156,500 | 0.48% | 725,000 | Up ×1 | |||
| ZURA Zura Bio Limited - Class A Ordinary shares | $22,035,709 | 0.45% | 3,734,866 | $-186,744 | |||
| TSM Taiwan Semiconductor Manufacturing Company Ltd. | $21,347,379 | 0.44% | 44,700 | $7,085,889 | Up ×2 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $20,823,507 | 0.43% | 675,430 | $-13,997,356 | Down ×1 | ||
| NVDA NVIDIA Corporation - Common Stock | $19,008,550 | 0.39% | 95,000 | $3,472,126 | Up ×2 | ||
| RZLT Rezolute, Inc. - Common Stock (NV) | $17,307,092 | 0.36% | 3,328,287 | $7,155,817 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $16,128,000 | 0.33% | 450,000 | $6,979,500 | |||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $14,446,297 | 0.30% | 8,497,822 | $-2,124,456 | |||
| NBIS Nebius Group N.V. - Class A Ordinary Shares | $14,360,840 | 0.30% | 52,000 | $2,572,251 | Down ×1 | ||
| MSFT Microsoft Corporation - Common Stock | $13,988,250 | 0.29% | 37,500 | $-1,329,385 | Down ×1 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $12,966,416 | 0.27% | 3,457,711 | $-3,284,826 | |||
| Unknown issuer (CUSIP: 370920100) | $12,418,075 | 0.26% | 736,104 | $3,216,775 | |||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $11,875,500 | 0.24% | 5,850,000 | $2,047,500 | |||
| ADAG Adagene Inc. - ADS, each representing 1.25 ordinary shares | $11,199,997 | 0.23% | 2,666,666 | Up ×1 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $10,912,037 | 0.22% | 1,007,575 | $-1,853,938 | |||
| Unknown issuer (CUSIP: 29286X101) | $10,824,025 | 0.22% | 6,256,662 | Up ×1 | |||
| WHWK Whitehawk Therapeutics, Inc. - Common Stock | $10,703,927 | 0.22% | 2,337,102 | $3,521,027 | Up ×1 | ||
| DDOG Datadog, Inc. - Class A Common Stock | $10,414,400 | 0.21% | 40,000 | $4,004,285 | Down ×1 | ||
| NOW ServiceNow, Inc. Common Stock | $9,928,000 | 0.20% | 100,000 | $822,740 | Up ×4 | ||
| AVGO Broadcom Inc. - Common Stock | $9,443,750 | 0.19% | 25,000 | $4,801,100 | Up ×2 | ||
| IONQ IonQ, Inc. Common Stock | $9,054,200 | 0.19% | 170,000 | $4,153,100 | |||
| MSFT Microsoft Corporation - Common Stock | $8,952,480 | 0.18% | 24,000 | Call option | Up ×1 | ||
| FROG JFrog Ltd. - Ordinary shares | $8,679,040 | 0.18% | 95,500 | $2,633,705 | Down ×1 | ||
| OCS Oculis Holding AG - Ordinary shares | $8,668,750 | 0.18% | 625,000 | Up ×1 | |||
| IREN IREN Limited - Ordinary Shares | $8,002,750 | 0.16% | 175,000 | $6,525,282 | Up ×1 | ||
| AMZN Amazon.com, Inc. - Common Stock | $7,746,050 | 0.16% | 32,500 | $-1,967,871 | Down ×3 | ||
| CRWD CrowdStrike Holdings, Inc. - Class A Common Stock | $7,631,400 | 0.16% | 10,000 | $-1,375,359 | Down ×1 | ||
| DSGN Design Therapeutics, Inc. - Common Stock | $7,570,878 | 0.16% | 523,212 | Up ×1 | |||
| PDD PDD Holdings Inc. - American Depositary Shares | $7,246,600 | 0.15% | 95,000 | $-1,275,314 | Up ×3 | ||
| MSLE Satellos Bioscience Inc. - Common Stock | $6,935,875 | 0.14% | 892,074 | $1,913,498 | |||
| DT Dynatrace, Inc. Common Stock | $6,806,050 | 0.14% | 155,000 | $1,259,050 | Up ×4 | ||
| AAPL Apple Inc. - Common Stock | $6,655,280 | 0.14% | 23,000 | Call option | Up ×1 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $6,214,902 | 0.13% | 427,141 | $-615,083 | |||
| VTVT vTv Therapeutics Inc. - Class A Common Stock | $6,136,950 | 0.13% | 163,000 | $-327,630 | |||
| Unknown issuer (CUSIP: 29014R301) | $5,552,000 | 0.11% | 400,000 | Up ×1 | |||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $5,338,025 | 0.11% | 411,250 | $1,024,012 | |||
| BABA Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share | $4,799,000 | 0.10% | 50,000 | Up ×1 | |||
| KRRO Korro Bio, Inc. - Common Stock | $4,582,923 | 0.09% | 347,718 | $646,755 | |||
| CLBT Cellebrite DI Ltd. - Ordinary Shares | $4,548,542 | 0.09% | 311,544 | $255,466 | |||
| IVVD Invivyd, Inc. - Common Stock | $4,362,000 | 0.09% | 5,000,000 | $-838,000 | Up ×1 | ||
| OUST Ouster, Inc. - Common Stock | $4,220,100 | 0.09% | 67,500 | Up ×1 | |||
| PALI Palisade Bio, Inc. - Common Stock | $4,180,000 | 0.09% | 2,000,000 | Up ×1 | |||
| AEVA Aeva Technologies, Inc. - Common Stock | $4,177,582 | 0.09% | 145,459 | $2,729,982 | Up ×1 | ||
| SEER Seer, Inc. - Class A Common Stock | $4,081,397 | 0.08% | 2,458,673 | $-49,174 | |||
| NBP NovaBridge Biosciences - American Depositary Shares | $3,909,241 | 0.08% | 2,004,739 | $-3,470,759 | Down ×1 | ||
| GTLB GitLab Inc. - Class A Common Stock | $3,816,250 | 0.08% | 125,000 | $1,652,250 | Up ×4 | ||
| Unknown issuer (CUSIP: 67613T104) | $3,742,000 | 0.08% | 200,000 | Up ×1 | |||
| FHTX Foghorn Therapeutics Inc. - Common Stock | $3,517,114 | 0.07% | 720,720 | $72,072 | |||
| AGEN Agenus Inc. - Common Stock | $3,256,605 | 0.07% | 1,064,250 | $-297,990 | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: 698955101) | $81,898,129 | 2,992,259 | 1.68% |
| ABVX | $76,757,760 | 576,000 | 1.58% |
| Unknown issuer (CUSIP: 423494103) | $76,649,413 | 2,086,834 | 1.58% |
| RLAY | $68,291,500 | 3,650,000 | 1.40% |
| Unknown issuer (CUSIP: 482931102) | $48,780,721 | 2,214,286 | 1.00% |
| COF | $34,429,401 | 171,615 | 0.71% |
| ORKA | $23,792,500 | 250,000 | 0.49% |
| Unknown issuer (CUSIP: 81221K108) | $23,790,264 | 1,095,316 | 0.49% |
| TYRA | $23,156,500 | 725,000 | 0.48% |
| ADAG | $11,199,997 | 2,666,666 | 0.23% |
| Unknown issuer (CUSIP: 29286X101) | $10,824,025 | 6,256,662 | 0.22% |
| MSFT | $8,952,480 | 24,000 | 0.18% |
| OCS | $8,668,750 | 625,000 | 0.18% |
| DSGN | $7,570,878 | 523,212 | 0.16% |
| AAPL | $6,655,280 | 23,000 | 0.14% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| MANE | Bought more | +150K | +$108.4M |
| TNGX | Bought more | +522K | +$74.8M |
| KYMR | Trimmed | -251K | +$71.2M |
| RYTM | Bought more | +411K | +$63.1M |
| ELVN | Bought more | +1.0M | +$60.8M |
| RVMD | Trimmed | -211K | +$60.5M |
| BCAX | Trimmed | -200K | +$50.9M |
| DFTX | Bought more | +500K | +$49.4M |
| SYRE | Bought more | +150K | +$44.7M |
| ARWR | Bought more | +100K | +$38.5M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ARGX | March 31, 2025 | 115,045 | $70,752,675 | 72.3% |
| APLS | March 31, 2026 | 2,578,396 | $64,769,308 | No longer tracked |
| BPMC | June 30, 2025 | 726,167 | $64,273,041 | No longer tracked |
| RNA | Dec. 31, 2025 | 1,285,610 | $56,014,028 | -81.8% |
| ASND | March 31, 2026 | 235,862 | $50,295,213 | 12.0% |
| SWTX | March 31, 2025 | 1,377,701 | $49,776,337 | No longer tracked |
| RAPT | March 31, 2026 | 1,375,000 | $46,571,250 | No longer tracked |
| RZLT | Dec. 31, 2025 | 4,870,000 | $45,778,000 | 104.0% |
| MRUS | Sept. 30, 2025 | 853,467 | $44,892,364 | No longer tracked |
| ZYME | March 31, 2026 | 1,680,121 | $44,237,586 | 10.6% |
| CNTA | June 30, 2026 | 1,053,464 | $41,843,590 | No longer tracked |
| MDGL | March 31, 2025 | 125,942 | $38,861,923 | 61.5% |
| ENGN | June 30, 2026 | 5,253,159 | $35,774,013 | 1.2% |
| SLNO | Dec. 31, 2025 | 467,342 | $31,592,319 | No longer tracked |
| APGE | Sept. 30, 2025 | 594,994 | $25,840,589 | 239.2% |
| MLYS | March 31, 2026 | 699,999 | $25,402,964 | 0.9% |
| MLTX | Sept. 30, 2025 | 508,267 | $23,990,202 | 129.3% |
| NAMS | Dec. 31, 2025 | 765,705 | $21,776,650 | -20.7% |
| CYTK | March 31, 2025 | 402,323 | $18,925,274 | 90.8% |
| FULC | June 30, 2026 | 2,350,000 | $18,024,500 | 7.2% |
| WVE | June 30, 2026 | 2,450,000 | $17,762,500 | -6.5% |
| IHS | March 31, 2026 | 2,357,520 | $17,587,099 | 1.2% |
| AKRO | Sept. 30, 2025 | 318,647 | $17,003,004 | No longer tracked |
| QURE | June 30, 2026 | 1,000,000 | $16,350,000 | 2.5% |
| QURE | Dec. 31, 2025 | 275,200 | $16,063,424 | 97.2% |
| UPB | March 31, 2026 | 588,450 | $15,976,418 | -21.9% |
| PRTA | June 30, 2025 | 1,283,555 | $15,883,993 | 51.4% |
| SMMT | June 30, 2025 | 695,000 | $13,406,550 | -39.1% |
| AVBP | Dec. 31, 2025 | 700,000 | $12,915,000 | 49.0% |
| KURA | March 31, 2025 | 1,339,942 | $11,670,895 | 92.9% |
| MNMD | March 31, 2026 | 800,000 | $10,712,000 | No longer tracked |
| BNTC | March 31, 2026 | 775,000 | $10,439,250 | 24.7% |
| PCVX | Sept. 30, 2025 | 295,543 | $9,608,103 | 72.8% |
| JANX | March 31, 2025 | 175,000 | $9,369,500 | -35.9% |
| IONS | March 31, 2025 | 250,000 | $8,740,000 | 100.0% |
| IOVA | March 31, 2025 | 1,106,040 | $8,184,696 | 128.7% |
| BCYC | June 30, 2026 | 1,560,882 | $7,242,492 | -2.6% |
| LXEO | March 31, 2026 | 720,622 | $7,155,776 | -7.4% |
| CRM | March 31, 2026 | 26,100 | $6,914,151 | 8.1% |
| CMPS | March 31, 2026 | 1,000,000 | $6,900,000 | 152.1% |
| BLLN | March 31, 2026 | 83,833 | $6,860,893 | 14.2% |
| SVRA | March 31, 2026 | 1,000,000 | $6,030,000 | 0.0% |
| XFOR | March 31, 2026 | 1,500,000 | $6,000,000 | 3.9% |
| VERA | Sept. 30, 2025 | 247,216 | $5,824,409 | 13.6% |
| RNAC | Dec. 31, 2025 | 563,272 | $5,756,640 | 34.1% |
| SLRN | March 31, 2025 | 1,729,665 | $5,431,148 | No longer tracked |
| PCRX | Sept. 30, 2025 | 225,000 | $5,377,500 | -4.9% |
| ELDN | Dec. 31, 2025 | 2,072,767 | $5,368,467 | 141.7% |
| ALMS | March 31, 2026 | 500,000 | $4,880,000 | 16.0% |
| META | March 31, 2026 | 7,169 | $4,732,185 | -4.7% |
| PEPG | March 31, 2026 | 700,000 | $4,557,000 | 63.8% |
| SGMT | March 31, 2026 | 724,771 | $4,290,644 | 107.9% |
| ADBE | March 31, 2026 | 12,051 | $4,217,729 | 11.4% |
| MTSR | June 30, 2025 | 150,000 | $4,083,000 | No longer tracked |
| PHAT | March 31, 2025 | 460,753 | $3,741,314 | 54.2% |
| IGMS | Sept. 30, 2025 | 3,255,826 | $3,646,525 | No longer tracked |
| EDU | March 31, 2026 | 62,000 | $3,411,860 | -1.8% |
| PRQR | Dec. 31, 2025 | 1,552,183 | $3,306,150 | 6.2% |
| VIGL | Sept. 30, 2025 | 411,191 | $3,268,968 | No longer tracked |
| FPS | June 30, 2026 | 100,000 | $2,927,000 | -38.0% |
| FCX | March 31, 2025 | 75,000 | $2,856,000 | 79.4% |
| ALVR | March 31, 2025 | 6,597,167 | $2,770,810 | No longer tracked |
| ZS | March 31, 2026 | 12,000 | $2,699,040 | 31.0% |
| OVID | March 31, 2025 | 2,850,000 | $2,661,045 | 827.9% |
| SE | March 31, 2025 | 25,000 | $2,652,500 | -10.8% |
| BDTX | March 31, 2026 | 1,046,517 | $2,543,036 | 2.8% |
| ESTC | March 31, 2025 | 25,000 | $2,477,000 | -3.9% |
| LPLA | June 30, 2025 | 7,500 | $2,453,550 | -1.0% |
| QCOM | March 31, 2026 | 14,000 | $2,394,700 | 25.6% |
| ARM | March 31, 2026 | 21,500 | $2,350,165 | 63.7% |
| MRVL | June 30, 2025 | 36,808 | $2,266,269 | 200.4% |
| BIOA | Dec. 31, 2025 | 382,406 | $2,248,547 | -18.0% |
| TIL | March 31, 2026 | 203,933 | $2,243,263 | -11.3% |
| RGNX | March 31, 2025 | 284,000 | $2,195,320 | 65.7% |
| PANW | March 31, 2026 | 11,450 | $2,109,090 | 124.0% |
| MU | June 30, 2026 | 6,000 | $2,027,040 | -19.7% |
| CRWV | March 31, 2026 | 27,500 | $1,969,275 | 15.8% |
| KDP | Dec. 31, 2025 | 77,050 | $1,965,546 | 10.8% |
| HUBS | Dec. 31, 2025 | 4,000 | $1,871,200 | -40.9% |
| CMG | Dec. 31, 2025 | 47,500 | $1,861,525 | -5.3% |
| AS | June 30, 2026 | 50,000 | $1,646,000 | 0.2% |
| UNH | Sept. 30, 2025 | 5,076 | $1,583,560 | 14.4% |
| SPOT | Dec. 31, 2025 | 2,173 | $1,516,754 | -7.9% |
| SARO | June 30, 2025 | 56,855 | $1,514,617 | -14.9% |
| NIQ | Dec. 31, 2025 | 95,000 | $1,491,500 | 6.9% |
| TRML | Sept. 30, 2025 | 91,426 | $1,461,902 | No longer tracked |
| RCKT | Sept. 30, 2025 | 591,263 | $1,448,594 | 8.7% |
| APLT | March 31, 2025 | 1,633,768 | $1,398,832 | No longer tracked |
| BILL | June 30, 2025 | 28,500 | $1,307,865 | 6.6% |
| PYPL | June 30, 2025 | 20,000 | $1,305,000 | -17.0% |
| VRNS | March 31, 2026 | 37,500 | $1,230,000 | 97.7% |
| BIRK | Sept. 30, 2025 | 25,000 | $1,229,500 | -17.7% |
| PEGA | June 30, 2025 | 16,500 | $1,147,080 | -37.9% |
| GBIO | March 31, 2026 | 201,419 | $1,144,060 | No longer tracked |
| HCA | March 31, 2025 | 3,750 | $1,125,563 | 21.7% |
| SAIL | Dec. 31, 2025 | 50,000 | $1,104,000 | -6.9% |
| ESTC | Dec. 31, 2025 | 12,500 | $1,056,125 | 13.5% |
| OMGAQ | March 31, 2025 | 1,323,530 | $986,824 | No longer tracked |
| MDB | June 30, 2025 | 5,500 | $964,700 | 103.7% |
| NKE | June 30, 2025 | 15,000 | $952,200 | -42.4% |
| PRMB | June 30, 2026 | 50,000 | $941,500 | -2.2% |
| INTC | June 30, 2025 | 40,000 | $908,400 | 311.4% |
| SEMR | Dec. 31, 2025 | 125,000 | $885,000 | No longer tracked |
| INFA | June 30, 2025 | 50,000 | $872,500 | No longer tracked |
| AS | Dec. 31, 2025 | 25,000 | $868,750 | -9.3% |
| ACHL | March 31, 2025 | 755,375 | $861,128 | No longer tracked |
| BA | June 30, 2025 | 5,000 | $852,750 | 5.8% |
| PINS | Dec. 31, 2025 | 25,000 | $804,250 | -10.2% |
| BASE | June 30, 2025 | 49,850 | $785,138 | No longer tracked |
| DLTR | March 31, 2025 | 10,000 | $749,400 | 79.6% |
| CFLT | Dec. 31, 2025 | 37,500 | $742,500 | No longer tracked |
| PCOR | Dec. 31, 2025 | 10,000 | $729,200 | -15.7% |
| HOOK | Sept. 30, 2025 | 566,640 | $711,133 | No longer tracked |
| TEAM | Sept. 30, 2025 | 3,500 | $710,815 | 4.8% |
| KRON | June 30, 2025 | 842,954 | $695,437 | No longer tracked |
| ALAB | Dec. 31, 2025 | 3,500 | $685,300 | 72.6% |
| RACE | June 30, 2025 | 1,500 | $636,364 | -14.2% |
| META | March 31, 2025 | 1,000 | $585,510 | -5.4% |
| USB | June 30, 2025 | 12,500 | $527,750 | 42.5% |
| NU | March 31, 2025 | 50,000 | $518,000 | 45.5% |
| CHYM | Dec. 31, 2025 | 25,000 | $504,250 | 30.2% |
| OXY | June 30, 2025 | 10,000 | $493,600 | 43.6% |
| MNDY | March 31, 2025 | 2,000 | $470,880 | -62.4% |
| CCC | Dec. 31, 2025 | 50,000 | $455,500 | -5.3% |
| KVUE | Dec. 31, 2025 | 25,000 | $405,750 | 10.0% |
| PCG | Sept. 30, 2025 | 25,000 | $348,500 | 18.9% |
| BZ | March 31, 2025 | 25,000 | $345,000 | -17.5% |
| GDS | June 30, 2025 | 12,500 | $316,625 | 6.6% |
| VRT | Dec. 31, 2025 | 2,000 | $301,720 | 60.9% |
| RDDT | Sept. 30, 2025 | 2,000 | $301,140 | -32.5% |
| DECK | Sept. 30, 2025 | 2,000 | $206,140 | -9.8% |
| CRBU | March 31, 2026 | 105,347 | $167,502 | -12.9% |
| CYCN | March 31, 2026 | 115,603 | $146,816 | 165.8% |
| IRWD | Dec. 31, 2025 | 110,532 | $144,797 | 31.3% |